Seven New Brain-Computer Interface Products Unveiled in Shanghai, Marking Accelerated Innovation in China's BCI Sector

(Source: Qianlong.com)

On December 4, the "Brain-Computer Interface Product Launch Event" of the 2025 Brain-Computer Interface Conference was held in Shanghai. At the event, seven representative companies in the brain-computer interface field launched five new invasive products and two new non-invasive products, covering areas such as neuromodulation, vision restoration, motor function recovery, and sleep intervention, showcasing China's leapfrog progress in brain-computer interface technology from fundamental research to clinical application.

Shanghai Mindtrix Technology Co., Ltd. (hereinafter referred to as Mindtrix) has released the second-generation 256-channel wireless implantable brain-computer interface system (WRS02) and a new-generation neuromodulation engineering prototype based on flexible neural microelectrode technology (hereinafter referred to as the deep brain stimulation system). It is reported that Mindtrix's first-generation 64-channel product (WRS01) has entered the review process of China's National Medical Products Administration.Innovative HealthcareSpecial Review Procedure for Devices; WRS02 has a wider application field than WRS01, connects to more devices, and operates more smoothly.

Deep Brain Stimulation System Targets Medical Applications for Neurological and Psychiatric Disorders Such as Parkinson’s Disease, Epilepsy, and Treatment-Resistant Depression. Zhang Shiqiang, Executive Director and Chief Product Officer of Step Medical, introduced that the company's self-developed ultra-flexible electrode technology is fundamental to the product's performance: "Our electrodes are currently the smallest neural electrodes in the world, about 1/100 the diameter of a human hair, with flexibility at the level of intercellular forces, enabling compatibility with brain tissue and reducing immune responses." It is reported that the system has completed preliminary functional verification in mice, monkeys, and humans.

Jia Fumin, founder of Shenfu Jianxing (Shanghai) Medical Device Co., Ltd., introduced the innovative concept of a "brain-spinal interface." This technology involves implanting electrodes into the brain's motor area and the spinal cord to create a "neural bridge" between the brain and spinal cord. It captures the patient’s movement intentions in real time and stimulates corresponding nerves, enabling paralyzed patients to achieve autonomous control of their lower limbs.

"Compared with traditional brain-computer interfaces, the integrated implant design of the 'brain-spinal interface' significantly reduces surgical trauma and improves signal acquisition stability," said Jia Fumin. According to reports, Jia Fumin's team has successfully completed the world's first four clinical concept validations of "paralyzed patients regaining the ability to walk through a brain-spinal interface" using their self-developed "three-in-one" brain-spinal interface technology. Four patients with severe spinal cord injuries achieved independent leg control and stepping within two weeks after the surgery.

Mindtrix Technology Co., Ltd. (hereinafter referred to as Mindtrix) has released its self-developed implantable brain-computer interface visual reconstruction system. This system integrates virtual reality with multi-channel neuromodulation technology, delivering stimulation signals through a visual neurophysiological signal stimulation module, and combining virtual reality technology to achieve visual function assessment and reconstructive intervention, offering new possibilities for restoring vision in visually impaired patients. It is reported that, through clinical trials, this system has achieved the world's first functional validation of quantifiable complex pattern and color perception.

"Although China started late in the brain-computer interface field and is generally far behind the United States, we can first make breakthroughs in some niche areas, which will then drive overall progress. The rapid development of China's supply chain in recent years, in particular, has given me a lot of surprises and expectations," said Liu Bing, Deputy Researcher at the Institute of Automation, Chinese Academy of Sciences, and Founder & CEO of Mindtrix.

In addition, four companies, including Hangzhou Shenzong Technology Co., Ltd., respectively released innovative achievements such as a multi-channel invasive flexible brain-computer interface system, "brain pacemaker," "Lanmao Sleep Pod" personalized insomnia regulation solution, and polysomnography monitor.

As core technologies continue to break through and clinical transformation accelerates, China's brain-computer interface industry is ushering in unprecedented development opportunities. "We hope relevant enterprises will focus on clinical needs, continuously tackle core technologies, and refine product quality, so that cutting-edge technology can truly benefit people's livelihood," said a relevant official from the Shanghai Science and Technology Commission.